Cited by 43Hormonal Regulation and HypertensionAdrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Predictors of successful outcome after adrenalectomy for primary aldosteronism

Open access
Wang, Wei, Hu, WeiLie, Zhang, XiaoMing, Wang, BangQi, Bin, Chen, Huang, Hai·2012·International Surgery

Abstract

The underlying cause of resistant hypertension after adrenalectomy for primary hyperaldosteronism remains controversial. The objective of this study was to identify preoperative factors predictive of resistant hypertension in patients after undergoing retroperitoneoscopic adrenalectomy. Between 2003 and 2009, 124 patients with unilateral aldosterone-producing adenoma or unilateral adrenal hyperplasia underwent retroperitoneoscopic adrenalectomy at our institution. Clinical and biochemical data were reviewed retrospectively at baseline and after a median follow-up time of 59.2 ± 37.2 months. Adrenalectomy cured hypertension in 68 patients (54.8%) and 43 (34.8%) had persistent hypertension that was much easier to control after surgery, whereas 13 patients (10.4%) had continued hypertension and poor blood pressure control. Multivariate regression analysis revealed that the main determinants of postoperative cure were duration of hypertension less than 5 years [odds ratio (OR): 6.515, 95% confidence interval (CI) 2.278-10.293), number of antihypertensive medications ≤2 (OR: 2.939, 95% CI 1.254-5.235), preoperative response to spironolactone (OR: 3.405, 95% CI 1.681-6.985), the TT genotype of the CYP11B2 gene (344 C/T) (OR: 2.765, 95% CI 1.221-4.986), and the presence of adenoma rather than hyperplasia (OR: 5.274, 95% CI 2.150-8.141). The main determinants of surgical cure or control of hypertension in patients with primary hyperaldosteronism were duration of hypertension, number of antihypertensive medications, preoperative response to spironolactone, the presence of adenoma, and CYP11B2 (344 C/T) genotype. Consideration of these factors may help in the evaluation of patients for surgery and for the identification of patients with continued postoperative hypertension that may require more long-term monitoring and treatment.

Integrity signals

Registry

Crossref · 10.9738/cc140.1

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Older patients and those with longstanding hypertension are more likely to have irreversible vascular damage and persistent hypertension requiring antihypertensive medication despite successful surgery.

    “Older patients and those with longstanding hypertension are more likely to have irreversible vascular damage and have persistent hypertension requiring antihypertensive medication, despite successful surgery (335).”

    From Adrenal incidentaloma (2020) · cites this paper as [335]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

  • Adrenal incidentaloma

    Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347 · see citing works

    “Older patients and those with longstanding hypertension are more likely to have irreversible vascular damage and have persistent hypertension requiring antihypertensive medication, despite successful surgery (335).”
    Background

Authors
Wang, W., Hu, W., Zhang, X., Wang, B., Bin, C., & Huang, H.
Affiliations
  • General Hospital of Guangzhou Military Command (CN)
  • Department of Urology, Guangzhou General Hospital of Guangzhou Military Command (Guangzhou Liuhuaqiao Hospital), Guangzhou, Guangdong province, China
  • Sun Yat-sen University (CN)
Venue
International Surgery
Published
2012-10
Volume
97
Issue
2
Pages
104-111
ISSN
  • 0020-8868 (ISSN-L)
  • 2520-2456
OpenAlex
W2076941575
Cited by
43
References
32
Citations by year
2024: 1 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 2 · 2013: 2
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • International Surgery (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
primary aldosteronism, adrenalectomy, retroperitoneoscopic adrenalectomy, resistant hypertension, postoperative hypertension, aldosterone-producing adenoma, adrenal hyperplasia, duration of hypertension, antihypertensive medication use, predictors of surgical outcome
MeSH terms
Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adrenalectomy, Adult, Decision Support Techniques, Female, Follow-Up Studies, Genetic Markers, Humans, Hyperaldosteronism, Hypertension, Hypokalemia, Male, Middle Aged, Laparoscopy, Retrospective Studies, Multivariate Analysis, Logistic Models, Treatment Outcome, Cytochrome P-450 CYP11B2, Polymorphism, Single Nucleotide, Preoperative Period, Genotyping Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review